Theodore E. Spiro

Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients

Alexander T Cohen, Theodore E. Spiro, Harry R. Büller et al. · New England Journal of Medicine · 2013 · 603 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease

Faı̈ez Zannad, Stefan D. Anker, William M. Byra et al. · New England Journal of Medicine · 2018 · 342 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

Alex C. Spyropoulos, Walter Ageno, Gregory W. Albers et al. · New England Journal of Medicine · 2018 · 246 citations · Full text

Medicine, Hematology, Pharmacotherapy +13

Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls

G. Contant, Theodore E. Spiro, Elisabeth Perzborn et al. · Thrombosis and Haemostasis · 2011 · 231 citations

Medicine, Pharmaceutical Analysis, Pharmacology +15

Prolonged Enoxaparin Therapy to Prevent Venous Thromboembolism After Primary Hip or Knee Replacement

Philip C. Comp, Theodore E. Spiro, Richard J. Friedman et al. · Journal of Bone and Joint Surgery · 2001 · 220 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17